Efficacy of tenofovir and efavirenz in combination with lamivudine or emtricitabine in antiretroviral-naive patients in Europe

Andrea De Luca, J. E. Swartz, L. Vandekerckhove, H. Ammerlaan, A. C. De Vries, J. Begovac, W. F.W. Bierman, C. A.B. Boucher, M. E. Van Der Ende, Z. Grossman, R. Kaiser, I. Levy, T. Mudrikova, R. Paredes, D. Perez-Bercoff, M. Pronk, C. Richter, J. C. Schmit, J. Vercauteren, M. ZazziS. Židovec Lepej, A. M.J. Wensing

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

The combination of tenofovir and efavirenz with either lamivudine or emtricitabine (TELE) has proved to be highly effective in clinical trials for first-line treatment of HIV-1 infection. However, limited data are available on its efficacy in routine clinical practice.
Original languageEnglish
Pages (from-to)1850-1857
Number of pages8
JournalJournal of Antimicrobial Chemotherapy
Volume70
DOIs
Publication statusPublished - 2015

Keywords

  • HIV-1
  • co-formulation
  • first-line antiretroviral therapy

Fingerprint Dive into the research topics of 'Efficacy of tenofovir and efavirenz in combination with lamivudine or emtricitabine in antiretroviral-naive patients in Europe'. Together they form a unique fingerprint.

Cite this